There is no recent research available for this condition. Please check back because thousands of new papers are published every week and we strive to find and display the most recent relevant research as soon as it is available.

Clinical Trials

Clinical Trial

Other

Status: Recruiting
Participants: 1000
Start Date: March 28, 2019

Longitudinal Studies of Patient With FPDMM

Clinical Trial

Drug

Status: Recruiting
Study Type: Drug
Participants: 174
Start Date: June 2011

Eltrombopag for the Treatment of Thrombocytopenia Due to Low- and Intermediate Risk Myelodysplastic Syndromes (EQol-MDS)

Clinical Trial

Drug

Status: Active, not recruiting
Study Type: Drug
Participants: 18
Start Date: October 2010

A Phase I Study Investigating the Combination of RAD001 With Standard Induction and Consolidation Therapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)

Clinical Trial

Drug

Status: Active, not recruiting
Study Type: Drug
Participants: 717
Start Date: April 2008

A Phase III Randomized, Double-Blind Study of Induction (Daunorubicin/Cytarabine) and Consolidation (High-Dose Cytarabine) Chemotherapy + Midostaurin (PKC412) (IND #101261) or Placebo in Newly Diagnosed Patients < 60 Years of Age With FLT3 Mutated Acute Myeloid Leukemia (AML)

View All Clinical Trials